Cyprotex Company Description
Cyprotex produces technological systems that monitor and evaluate drug discovery experiments. The discoveries in question focus on the ADME properties (absorption, distribution, metabolism, and excretion). The UK-based company's ADME-related top products include its Cloe Screen, an in vitro toxicity service, and Cloe PK, a pharmacokinetics prediction system. Cyprotex entered into a partnership with Sepracor that expanded the company's reach into the US.
View the Comprehensive Company Description for Cyprotex
The Company Description provides a historical perspective of Cyprotex's organization from inception to current status.
Produced by Hoover's in-house editorial team, the Company Description tracks ownership transitions, company progress via mergers and acquisitions, major growth milestones, and strategic initiatives, to provide a holistic view of Cyprotex's evolution in the marketplace.
